PARP regulates TGF-β receptor type II expression in estrogen receptor-positive breast cancer cell lines

被引:0
|
作者
Sterling, Julie A. [1 ]
Wu, Liang [1 ]
Banerji, Sunandita S. [1 ]
机构
[1] Med Univ Ohio, Dept Biochem & Canc Biol, Toledo, OH 43614 USA
关键词
TGF-beta receptor type II; estrogen receptor-positive; breast cancer; PARP; CCAAT box;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Expression of the tumor suppressor gene, transforming growth factor beta receptor type II (T beta RII) is often reduced in estrogen receptor-positive breast cancer cells leading to uninhibited tumor cell growth. A clear understanding of its regulation is necessary to identify potential mechanisms to re-express this tumor suppressor gene. Materials and Methods: The regulation of T beta RII expression was studied by utilizing 5' promoter deletion constructs, followed by EMSA analyses. The resulting binding protein was affinity purified and identified by mass spectrophotometry. Results: An inverted CCAAT box centered at -79 was found to be essential for T beta RII promoter activity. Purification of the protein binding to this region and subsequent mass spectrophotometric analysis identified the binding protein as poly(ADP-ribose)polyinerase I (PARP). ChIP assays verified that PARP interacted with the TPRII promoter in vivo. Conclusion: The present study demonstrated that PARP is important for T beta RII expression in estrogen receptor-positive breast cancer cell lines.
引用
收藏
页码:1893 / 1901
页数:9
相关论文
共 50 条
  • [1] Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer
    Agrawal, Anil
    Ziolkowski, Piotr
    Grzebieniak, Zygmunt
    Jelen, Michal
    Bobinski, Piotr
    Agrawal, Siddarth
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (08) : 550 - 555
  • [2] The impact of CBP expression in estrogen receptor-positive breast cancer
    Wafaa S. Ramadan
    Iman M. Talaat
    Mahmood Y. Hachim
    Annette Lischka
    Timo Gemoll
    Raafat El-Awady
    Clinical Epigenetics, 2021, 13
  • [3] The impact of CBP expression in estrogen receptor-positive breast cancer
    Ramadan, Wafaa S.
    Talaat, Iman M.
    Hachim, Mahmood Y.
    Lischka, Annette
    Gemoll, Timo
    El-Awady, Raafat
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [4] Treatment of Estrogen Receptor-Positive Breast Cancer
    Lumachi, F.
    Brunello, A.
    Maruzzo, M.
    Basso, U.
    Basso, S. M. M.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (05) : 596 - 604
  • [5] Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer
    Tokunaga, Eriko
    Hisamatsu, Yuichi
    Taketani, Kenji
    Yamashita, Nami
    Akiyoshi, Sayuri
    Okada, Satoko
    Tanaka, Kimihiro
    Saeki, Hiroshi
    Oki, Eiji
    Aishima, Shinichi
    Oda, Yoshinao
    Morita, Masaru
    Maehara, Yoshihiko
    CANCER MEDICINE, 2013, 2 (06): : 763 - 773
  • [6] Equol as a potent radiosensitizer in estrogen receptor-positive and -negative human breast cancer cell lines
    Taghizadeh, Bita
    Ghavami, Laleh
    Nikoofar, Alireza
    Goliaei, Bahram
    BREAST CANCER, 2015, 22 (04) : 382 - 390
  • [7] Equol as a potent radiosensitizer in estrogen receptor-positive and -negative human breast cancer cell lines
    Bita Taghizadeh
    Laleh Ghavami
    Alireza Nikoofar
    Bahram Goliaei
    Breast Cancer, 2015, 22 : 382 - 390
  • [8] PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells
    Gadad, Shrikanth S.
    Camacho, Cristel, V
    Malladi, Venkat
    Hutti, Charles R.
    Nagari, Anusha
    Kraus, W. Lee
    MOLECULAR CANCER RESEARCH, 2021, 19 (10) : 1688 - 1698
  • [9] Trichostatin A-Induced TGF-β Type II Receptor Expression in Retinoblastoma Cell Lines
    Kashiwagi, Yoshiko
    Horie, Kuniko
    Kanno, Chikako
    Inomata, Motoko
    Imamura, Takashi
    Kato, Mitsuyasu
    Yamamoto, Teiko
    Yamashita, Hidetoshi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (02) : 679 - 685
  • [10] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Ximena García
    Andrés Elía
    Lucrecia Galizzi
    María May
    Eunice Spengler
    Paula Martínez Vázquez
    Javier Burruchaga
    Hugo Gass
    Claudia Lanari
    Caroline A. Lamb
    Breast Cancer Research and Treatment, 2020, 180 : 257 - 263